Mapp Biopharmaceutical, INC.
UEI M9V9QTHR1H28 · CA · SAM.gov record ↗
Obligations by agency
- Department Of Health And Human Services$83.7M
- Department Of Defense$192K
Obligations by NAICS
Monthly obligations
Contracts ending within 18 months (recompete watch)
- HHSO100201600021C ↗$-2.1M
SUPPORT THE INITIATION, MAINTENANCE, AND EXECUTION OF A ZMAPP EAP IN THE US AND AFRICA, INCLUDING CLINICAL, QUALITY, REGULATORY, AND OPERATIONAL SUPPORT AS WELL AS THE EARLY CLINICAL STUDIES (PHASE 1) REQUIRED TO ENABLE FIELD USE OF MBP091 AND MBP134
- Ends
- Dec 30, 2027
- Started
- Jun 26, 2016
- Agency
- Office Of Assistant Secretary For Preparedness And Response
- NAICS
- 541720
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| HHSO100201600021C ↗ | SUPPORT THE INITIATION, MAINTENANCE, AND EXECUTION OF A ZMAPP EAP IN THE US AND AFRICA, INCLUDING CLINICAL, QUALITY, REGULATORY, AND OPERATIONAL SUPPORT AS WELL AS THE EARLY CLINICAL STUDIES (PHASE 1) REQUIRED TO ENABLE FIELD USE OF MBP091 AND MBP134 | Office Of Assistant Secretary For Preparedness And Response | 541720 | $-2.1M | Jun 26, 2016 | Dec 30, 2027 |
Largest awards
- 75A50122C00061 ↗$85.8M
PROCUREMENT OF THERAPEUTICS FOR EBOLA, SUDAN AND MARBURG VIRUSES - INCORPORATE RATE LETTER MOD
- Ends
- Sep 29, 2031
- Started
- Sep 29, 2022
- Agency
- Office Of Assistant Secretary For Preparedness And Response
- NAICS
- 541714
- HT942525F0237 ↗$111K
ANTIBODY & ANTIGEN SUPPLY
- Ends
- Dec 3, 2025
- Started
- Jun 5, 2025
- Agency
- Defense Health Agency
- NAICS
- 325413
- HT942525FE048 ↗$61K
HUMAN-DERIVED MONOCLONAL ANTIBODIES AND RECOMBINANT ANTIGENS
- Ends
- Feb 24, 2026
- Started
- Sep 18, 2025
- Agency
- Defense Health Agency
- NAICS
- 325413
- 75A50124C00003 ↗$43K
NO COST MODIFICATION TO TRANSFER GOVERNMENT FURNISHED PROPERTY UNDER BARDA CONTRACT NO. 75A50122C00076 TO BARDA CONTRACT NO. 75A50124C00003.
- Ends
- Dec 30, 2032
- Started
- Mar 19, 2024
- Agency
- Office Of Assistant Secretary For Preparedness And Response
- NAICS
- 541714
- HT942626FE011 ↗$21K
PROCUREMENT OF HUMAN DERIVED MONOCLONAL ANTIBODIES AND ANTIGENS
- Ends
- Apr 23, 2026
- Started
- Feb 5, 2026
- Agency
- Defense Health Agency
- NAICS
- 325413
UPDATE CONTRACTING OFFICER AND INDIRECT RATES
- Ends
- Jun 29, 2022
- Started
- Sep 12, 2017
- Agency
- Office Of Assistant Secretary For Preparedness And Response
- NAICS
- 541711
ADVANCE MBP134, A COCKTAIL OF TWO HUMAN MONOCLONAL ANTIBODIES (MBP047 AND MBP087), AS A POTENTIAL MEDICAL COUNTERMEASURE TO TREAT ACTIVE INFECTIONS OF SUDAN VIRUS - UPDATE INDIRECT RATES LETTER
- Ends
- Dec 30, 2024
- Started
- Sep 24, 2018
- Agency
- Office Of Assistant Secretary For Preparedness And Response
- NAICS
- 541715
THE PURPOSE OF THIS NO-COST MODIFICATION IS TO CORRECT THE PERIOD OF PERFORMANCE FOR CLIN0001 TO ALIGN WITH IPP.
- Ends
- Jun 29, 2026
- Started
- Sep 29, 2020
- Agency
- Office Of Assistant Secretary For Preparedness And Response
- NAICS
- 541714
THIS MOD TRANSFERS GFP BETWEEN CONTRACTS.
- Ends
- Apr 30, 2031
- Started
- Sep 27, 2022
- Agency
- Office Of Assistant Secretary For Preparedness And Response
- NAICS
- 541714
MATERIAL REQUIREMENT FOR THE DELIVERY OF ANTIBODY AND ANTIGEN SUPPLY.
- Ends
- —
- Started
- May 31, 2025
- Agency
- Defense Health Agency
- NAICS
- 325413
NO COST MODIFICATION TO CHANGE PRIMARY AND SECONDARY COR.
- Ends
- —
- Started
- Jun 2, 2019
- Agency
- Office Of Assistant Secretary For Preparedness And Response
- NAICS
- 541714
- HHSO100201600021C ↗$-2.1M
SUPPORT THE INITIATION, MAINTENANCE, AND EXECUTION OF A ZMAPP EAP IN THE US AND AFRICA, INCLUDING CLINICAL, QUALITY, REGULATORY, AND OPERATIONAL SUPPORT AS WELL AS THE EARLY CLINICAL STUDIES (PHASE 1) REQUIRED TO ENABLE FIELD USE OF MBP091 AND MBP134
- Ends
- Dec 30, 2027
- Started
- Jun 26, 2016
- Agency
- Office Of Assistant Secretary For Preparedness And Response
- NAICS
- 541720
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| 75A50122C00061 ↗ | PROCUREMENT OF THERAPEUTICS FOR EBOLA, SUDAN AND MARBURG VIRUSES - INCORPORATE RATE LETTER MOD | Office Of Assistant Secretary For Preparedness And Response | 541714 | $85.8M | Sep 29, 2022 | Sep 29, 2031 |
| HT942525F0237 ↗ | ANTIBODY & ANTIGEN SUPPLY | Defense Health Agency | 325413 | $111K | Jun 5, 2025 | Dec 3, 2025 |
| HT942525FE048 ↗ | HUMAN-DERIVED MONOCLONAL ANTIBODIES AND RECOMBINANT ANTIGENS | Defense Health Agency | 325413 | $61K | Sep 18, 2025 | Feb 24, 2026 |
| 75A50124C00003 ↗ | NO COST MODIFICATION TO TRANSFER GOVERNMENT FURNISHED PROPERTY UNDER BARDA CONTRACT NO. 75A50122C00076 TO BARDA CONTRACT NO. 75A50124C00003. | Office Of Assistant Secretary For Preparedness And Response | 541714 | $43K | Mar 19, 2024 | Dec 30, 2032 |
| HT942626FE011 ↗ | PROCUREMENT OF HUMAN DERIVED MONOCLONAL ANTIBODIES AND ANTIGENS | Defense Health Agency | 325413 | $21K | Feb 5, 2026 | Apr 23, 2026 |
| HHSO100201700023C ↗ | UPDATE CONTRACTING OFFICER AND INDIRECT RATES | Office Of Assistant Secretary For Preparedness And Response | 541711 | $0 | Sep 12, 2017 | Jun 29, 2022 |
| 75A50118C00024 ↗ | ADVANCE MBP134, A COCKTAIL OF TWO HUMAN MONOCLONAL ANTIBODIES (MBP047 AND MBP087), AS A POTENTIAL MEDICAL COUNTERMEASURE TO TREAT ACTIVE INFECTIONS OF SUDAN VIRUS - UPDATE INDIRECT RATES LETTER | Office Of Assistant Secretary For Preparedness And Response | 541715 | $0 | Sep 24, 2018 | Dec 30, 2024 |
| 75A50120C00198 ↗ | THE PURPOSE OF THIS NO-COST MODIFICATION IS TO CORRECT THE PERIOD OF PERFORMANCE FOR CLIN0001 TO ALIGN WITH IPP. | Office Of Assistant Secretary For Preparedness And Response | 541714 | $0 | Sep 29, 2020 | Jun 29, 2026 |
| 75A50122C00076 ↗ | THIS MOD TRANSFERS GFP BETWEEN CONTRACTS. | Office Of Assistant Secretary For Preparedness And Response | 541714 | $0 | Sep 27, 2022 | Apr 30, 2031 |
| HT942525D0009 ↗ | MATERIAL REQUIREMENT FOR THE DELIVERY OF ANTIBODY AND ANTIGEN SUPPLY. | Defense Health Agency | 325413 | $0 | May 31, 2025 | — |
| 75A50119D00018 ↗ | NO COST MODIFICATION TO CHANGE PRIMARY AND SECONDARY COR. | Office Of Assistant Secretary For Preparedness And Response | 541714 | $0 | Jun 2, 2019 | — |
| HHSO100201600021C ↗ | SUPPORT THE INITIATION, MAINTENANCE, AND EXECUTION OF A ZMAPP EAP IN THE US AND AFRICA, INCLUDING CLINICAL, QUALITY, REGULATORY, AND OPERATIONAL SUPPORT AS WELL AS THE EARLY CLINICAL STUDIES (PHASE 1) REQUIRED TO ENABLE FIELD USE OF MBP091 AND MBP134 | Office Of Assistant Secretary For Preparedness And Response | 541720 | $-2.1M | Jun 26, 2016 | Dec 30, 2027 |